Cheng Du1, Xin Guan1, Yao Liu1, Zhuxuan Xu1, Xiaowei Du1, Baolei Li1, Meiling Wang1, Zhendong Zheng2. 1. Department of Oncology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, People's Republic of China. 2. Department of Oncology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, People's Republic of China. gcp_zzd@sina.com.
Abstract
PURPOSE: Disulfiram (DSF) is an approved drug for the treatment of alcohol dependence. Accumulating evidence indicates that DSF, alone or in combination with copper (Cu), possesses strong antitumor activity in various malignancies. This study investigated the effects of DSF on gastric cancer (GC) and the potential mechanisms involved. METHODS: GC cell proliferation and apoptosis upon treatment with DSF with or without copper were analyzed using CCK-8 assay, colony formation assay, and flow cytometry. Glucose metabolism was investigated using glucose consumption and lactate production assays. The expression of caspase-3, Bcl-2, LC-3, P62, S6K1, c-Myc, GLUT1, PKM2, and LDHA was analyzed using western blot assay. In vivo nude mice studies were performed to verify the findings from in vitro analyses. RESULTS: Our study showed that DSF was highly toxic to GC cells in a Cu-dependent manner. Nontoxic concentrations of Cu enhanced the inhibitory effects of DSF on cell viability and colony formation. DSF also induced apoptotic and autophagic cell death in the presence of Cu. In addition, DSF/Cu inhibited glycolysis and xenograft growth of GC cells by suppressing the expression of S6K1, c-Myc, and their downstream molecules, including GLUT1, PKM2, and LDHA. CONCLUSION: Our study demonstrated that DSF/Cu exerted antitumor activity against GC cells both in vitro and in vivo. DSF/Cu may represent a promising therapeutic strategy for the treatment of GC.
PURPOSE: Disulfiram (DSF) is an approved drug for the treatment of alcohol dependence. Accumulating evidence indicates that DSF, alone or in combination with copper (Cu), possesses strong antitumor activity in various malignancies. This study investigated the effects of DSF on gastric cancer (GC) and the potential mechanisms involved. METHODS: GC cell proliferation and apoptosis upon treatment with DSF with or without copper were analyzed using CCK-8 assay, colony formation assay, and flow cytometry. Glucose metabolism was investigated using glucose consumption and lactate production assays. The expression of caspase-3, Bcl-2, LC-3, P62, S6K1, c-Myc, GLUT1, PKM2, and LDHA was analyzed using western blot assay. In vivo nude mice studies were performed to verify the findings from in vitro analyses. RESULTS: Our study showed that DSF was highly toxic to GC cells in a Cu-dependent manner. Nontoxic concentrations of Cu enhanced the inhibitory effects of DSF on cell viability and colony formation. DSF also induced apoptotic and autophagic cell death in the presence of Cu. In addition, DSF/Cu inhibited glycolysis and xenograft growth of GC cells by suppressing the expression of S6K1, c-Myc, and their downstream molecules, including GLUT1, PKM2, and LDHA. CONCLUSION: Our study demonstrated that DSF/Cu exerted antitumor activity against GC cells both in vitro and in vivo. DSF/Cu may represent a promising therapeutic strategy for the treatment of GC.
Authors: N C Yip; I S Fombon; P Liu; S Brown; V Kannappan; A L Armesilla; B Xu; J Cassidy; J L Darling; W Wang Journal: Br J Cancer Date: 2011-04-12 Impact factor: 7.640
Authors: P Liu; S Brown; T Goktug; P Channathodiyil; V Kannappan; J-P Hugnot; P-O Guichet; X Bian; A L Armesilla; J L Darling; W Wang Journal: Br J Cancer Date: 2012-10-02 Impact factor: 7.640
Authors: Juan Cong; Yangyang Wang; Xiao Zhang; Nan Zhang; Ling Liu; Klara Soukup; Theodoros Michelakos; Theodore Hong; Albert DeLeo; Lei Cai; Francesco Sabbatino; Soldano Ferrone; Hang Lee; Vera Levina; Bryan Fuchs; Kenneth Tanabe; Keith Lillemoe; Cristina Ferrone; Xinhui Wang Journal: Cancer Lett Date: 2017-08-30 Impact factor: 9.756